FR2602682B1 - Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiff - Google Patents
Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiffInfo
- Publication number
- FR2602682B1 FR2602682B1 FR8611643A FR8611643A FR2602682B1 FR 2602682 B1 FR2602682 B1 FR 2602682B1 FR 8611643 A FR8611643 A FR 8611643A FR 8611643 A FR8611643 A FR 8611643A FR 2602682 B1 FR2602682 B1 FR 2602682B1
- Authority
- FR
- France
- Prior art keywords
- osid
- immunotoxins
- vivo
- oxidation
- patterns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8611643A FR2602682B1 (fr) | 1986-08-12 | 1986-08-12 | Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiff |
IL80972A IL80972A (en) | 1985-12-20 | 1986-12-15 | Modified ribosome-inactivating glycoproteins,their preparation,immunotoxins containing them and pharmaceutical compositions containing such immunotoxins |
US06/941,990 US4911911A (en) | 1985-12-20 | 1986-12-15 | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein |
DE8686402812T DE3676187D1 (de) | 1985-12-20 | 1986-12-16 | Die ribosome inhibierende, mittels oxidation und bildung von schiffbasen modifizierte glukoproteine, verfahren zur herstellung derselben und ein solches glukoprotein enthaltende immunotoxine. |
AT86402812T ATE59049T1 (de) | 1985-12-20 | 1986-12-16 | Die ribosome inhibierende, mittels oxidation und bildung von schiffbasen modifizierte glukoproteine, verfahren zur herstellung derselben und ein solches glukoprotein enthaltende immunotoxine. |
ES86402812T ES2020945B3 (es) | 1985-12-20 | 1986-12-16 | Glicoproteinas modificadas por oxidacion y formacion de bases de schiff, que inhiben los ribosomas, procedimiento de obtencion e inmunotoxinas que comprenden una glicoproteina como esta. |
EP86402812A EP0234151B1 (fr) | 1985-12-20 | 1986-12-16 | Glycoprotéines modifiées par oxydation et formation de base de Schiff, inhibant les ribosomes, procédé d'obtention et immunotoxines comprenant une telle glycoprotéine |
AU66630/86A AU602320B2 (en) | 1985-12-20 | 1986-12-17 | Ribosome inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged-action immunotoxins containing such a glycoprotein |
CA000525646A CA1276108C (fr) | 1985-12-20 | 1986-12-17 | Procede de modification des glycoproteines inactivant les ribosomes par oxydation des groupements oside et formation d'une base de schiff |
PT83946A PT83946B (pt) | 1985-12-20 | 1986-12-17 | Processo para a obtencao de glicoproteinas inibidoras dos ribosomas, modificadas por oxidacao das funcoes osidicas e formacao de uma base de schiff |
IE330586A IE59649B1 (en) | 1985-12-20 | 1986-12-18 | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and invivo prolonged-action immunotoxins containing such a glycoprotein |
DK611886A DK611886A (da) | 1985-12-20 | 1986-12-18 | Riboson-inaktiverende glycoproteiner og immunotoksiner med forlaengetvirkning in vivo, der indeholder et saadant glycoprotein |
NZ218705A NZ218705A (en) | 1985-12-20 | 1986-12-18 | Glycoproteins with ribosome-inhibiting properties and immunotoxins |
AR86306243A AR242958A1 (es) | 1985-12-20 | 1986-12-19 | Un procedimiento para la obtencion de un gpir modificada, y procedimiento para obtener una inmunotoxina utilizando dicho gpir modificada. |
KR1019860011019A KR950007215B1 (ko) | 1985-12-20 | 1986-12-20 | 오시딕 단위를 산화시키고 쉬프염기를 형성하여 리보솜을 비활성화시키는 당단백질을 변형시키는 방법 |
JP61302889A JPH0742316B2 (ja) | 1985-12-20 | 1986-12-20 | オシド単位の酸化およびシツフ塩基の形成により変性されたリボソ−ム不活性化糖タンパク、およびこの糖タンパクを含む生体内持続性免疫毒素 |
US07/404,052 US5104976A (en) | 1985-12-20 | 1989-09-08 | Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein |
GR91400316T GR3001597T3 (en) | 1985-12-20 | 1991-03-12 | Glycoproteins modified by oxidation and formation of schiff bases, inhibiting ribosomes, process for obtaining the same, and immunotoxines containing such glycoprotein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8611643A FR2602682B1 (fr) | 1986-08-12 | 1986-08-12 | Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiff |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2602682A1 FR2602682A1 (fr) | 1988-02-19 |
FR2602682B1 true FR2602682B1 (fr) | 1988-12-02 |
Family
ID=9338239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR8611643A Expired FR2602682B1 (fr) | 1985-12-20 | 1986-08-12 | Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiff |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2602682B1 (fr) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4664911A (en) * | 1983-06-21 | 1987-05-12 | Board Of Regents, University Of Texas System | Immunotoxin conjugates employing toxin B chain moieties |
PT80662B (en) * | 1984-06-20 | 1986-12-09 | Sanofi Sa | Process to obtain anti-tumoral glycoprotein modified on its glycidic portions |
-
1986
- 1986-08-12 FR FR8611643A patent/FR2602682B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2602682A1 (fr) | 1988-02-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL134374A0 (en) | Preparation of 3,3-dimethylbutyraldehyde by oxidation of 3,3-dimethylbutanol | |
FR2703993B1 (fr) | Utilisation en cosmétique de dérivés lipophiles des amino déoxyalditols, compositions cosmétiques les contenant, et nouveaux carbamates d'alkyle. | |
IT1284758B1 (it) | Utilizzo della vitamina c o di suoi derivati o analoghi per stimolare la sintesi dell'elastina cutanea. | |
PL335160A1 (en) | Treatment of hiv and carcinoma | |
IL92337A (en) | Combined shirt and religious garment | |
EP0239391A3 (en) | New 1,2,6-triphenyl-4(1h)- pyridinone and pyridinethione derivatives, production and uses thereof | |
DE3752293D1 (de) | Neue Blockcopolymere und ihre Herstellung | |
DE3674375D1 (de) | Fluessigkeitsgekuehlter homopolargeneratorlaeufer und sein herstellungsverfahren. | |
GB2156806B (en) | Production of diphenylamines or n,n'-diphenyl-phenylenediamines | |
GB2216891B (en) | 'plant ribosome inactivating protein derived from saponaria officinalis' | |
FR2602682B1 (fr) | Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiff | |
FR2602683B1 (fr) | Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques puis reduction | |
PT83946A (fr) | Procede pour l:obtention de glycoproteines inhibant les ribosomes modifiees par oxydation des motifs osidiques et formation d:une base de schiff | |
ZA894541B (en) | Selective production of 2,6-diethylnaphthalene | |
FR2591895B1 (fr) | Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiques | |
CZ78095A3 (en) | Novel 17 beta-substituted derivatives of 4-azaandrostane, pharmaceutical preparations based thereon and process of their preparation | |
MA22329A1 (fr) | Pain de detergent synthetique avec des sulfates d'alkyle a longue chaine pour ameliorer la faculte de mise en oeuvre et les caracteristiques du pain | |
FR2591894B1 (fr) | Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiques | |
FR2653996B1 (fr) | Composition et solution aqueuse pour la repousse des cheveux. | |
FR2755968B1 (fr) | Nouveaux derives silicies de flavones filtres, compositions cosmetiques photoprotectrices les contenant et utilisations | |
OA09221A (fr) | "Synthèse asymétrique des dérivés de la furo (3, 4-c) pyridine". | |
FR2627755B3 (fr) | Article d'hygiene comportant un motif anti-inhibition | |
IT8823100A0 (it) | Nuova sintesi della 2, 2'-a2-bis-ossazolina | |
MD1492F1 (en) | Oxidated tomatozid possessing antiviral activity | |
RO103191B1 (en) | Synthesis process of 2, 2, 6, 6-tetramethyl-piperidinyl |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |